Table 1.

Patient characteristics

Variables	All patients (n = 77)			Propensity score matched patients (50 pairs)
	Normalized group	Non-normalized group	P	Normalized group	Non-normalized group	p
	(n = 37)	(n = 40)		(n = 25)	(n = 25)
	No. of patients (%)	No. of patients (%)		No. of patients (%)	No. of patients (%)
Age (years)			0.279			0.929
Median	62	59		58	60
Range	47–78	39–78		50–69	39–78
Gender			0.550			0.747
Male	29 (78.4)	29 (72.5)		19 (76.0)	18 (72.0)
Female	8 (21.6)	11 (27.5)		6 (24.0)	7 (28.0)
ECOG PS			0.197			0.156
0	23 (62.2)	19 (47.5)		16 (64.0)	11 (44.0)
1–2	14 (37.8)	21 (52.5)		9 (36.0)	14 (56.0)
Child-Pugh classification			0.945			0.480
A	28 (75.7)	30 (75.0)		19 (76.0)	21 (84.0)
B	9 (24.3)	10 (25.0)		6 (24.0)	4 (16.0)
Viral etiology			0.402			1.000
HBs-Ag (+)	29 (78.4)	28 (70.0)		20 (80.0)	20 (80.0)
HBs-Ag (−)	8 (21.6)	12 (30.0)		5 (20.0)	5 (20.0)
Tumor size (cm)			0.488			0.344
Median	2.0	1.7		2.1	1.6
Range	0.8–4.5	1.0–4.4		1.0–4.5	1.2–3.6
Initial AFP (ng/mL)			0.187			0.655
Median	48.6	128.0		50.2	113.0
Range	20.8–1870.0	20.3–3250.0		21.2–1870.0	20.3–2490.0
ALT			0.093			0.981
Median	25	28.5		27	25
Range	9–55	11–185		9–55	14–116
Albumin			0.383			0.395
Median	3.6	3.4		3.4	3.6
Range	2.4–4.5	2.4–4.7		2.4–4.5	2.9–4.7
Bilirubin			0.841			0.804
Median	1.1	1.1		1.0	1.0
Range	0.5–3.5	0.6–6.2		0.5–2.9	0.6–6.2
INR			0.550			0.514
Median	1.1	1.1		1.2	1.1
Range	0.9–1.5	0.9–1.7		0.9–1.5	0.9–1.7
Radiation dose			0.909			0.743
Median	45	45		45	45
Range	36–60	36–60		36–60	36–60

Abbreviations: ECOG PS Eastern Cooperative Oncology Group performance status, HBs-Ag hepatitis B surface-antigen, AFP alpha-fetoprotein, ALT alanine aminotransferase, INR international normalized ratio